Statement from Margarida Jorge, Campaign Director, Lower Drug Prices Now, on the news that early trials of Gilead’s Remdesivir have shown positive results

“This is great news. But based on Gilead’s record, we’re deeply concerned that they’ll use their monopoly control to price-gouge patients and make this potentially life-saving treatment unaffordable and inaccessible. Remdesivir was developed using tens of millions of taxpayer dollars, and should be made available at no additional cost. Congress and the Trump administration must require that COVID vaccines and treatments be affordable for all, before it’s too late.”

Background: Gilead has a history of gouging patients.

###

Lower Drug Prices Now is a national coalition of nearly 60 social, racial and economic justice organizations with members in all fifty states. We are committed to transformative, systemic and bold reforms to ensure everyone has access to affordable medicines — no matter where they live, what they look like or how much money they have. Learn more at www.lowerdrugpricesnow.org and follow us on Twitter @peopleb4pharma.

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles